RADX TECH PROJECT, L3 HEALTHCARE, LLC: RADX PERFORMANCE EVALUATION OF YUKON SWABS

$1.73M USD

Funder	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Recipient Organization	Unknown
Country	United States
Start Date	Jan 12, 2021
End Date	Feb 28, 2021
Duration	47 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10506141`

Grant Description

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has an open solicitation for proposals to provide up to $500 million across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public?s safe return to normal activities.

Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN).

RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches.

RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.